Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease

INTRODUCTION: Combining long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agonists (LABAs) is beneficial in chronic obstructive pulmonary disease (COPD), as the two classes of bronchodilator have complementary modes of action. The optimal dose for the fixed-dose combination of the LAMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Aalbers, René, Maleki-Yazdi, M. Reza, Hamilton, Alan, Waitere-Wijker, Stella, Zhao, Yihua, Amatto, Valeria C., Schmidt, Olaf, Bjermer, Leif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604503/
https://www.ncbi.nlm.nih.gov/pubmed/26404912
http://dx.doi.org/10.1007/s12325-015-0239-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604503/
https://www.ncbi.nlm.nih.gov/pubmed/26404912
http://dx.doi.org/10.1007/s12325-015-0239-8

Ejemplares similares